Predictions
Quoin Pharmaceuticals Ltd. ADR
Start price
Target price
Perf. (%)
€3.06
03.09.22
03.09.22
-
03.09.23
03.09.23
-86.05%
24.04.23
24.04.23
Risky Investment
Invitae Corp
Start price
Target price
Perf. (%)
€2.76
02.09.22
02.09.22
-
02.09.23
02.09.23
-10.51%
27.09.22
27.09.22
Could be very worthwhile Investment >20% year
Abivax S.A.
Start price
Target price
Perf. (%)
€8.30
02.09.22
02.09.22
€5.00
31.12.24
31.12.24
85.30%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Nuwellis Inc.
Start price
Target price
Perf. (%)
€1.69
31.08.22
31.08.22
-
31.08.23
31.08.23
-93.25%
18.05.23
18.05.23
Could be very worthwhile Investment >20% year
Nuwellis Inc.
Start price
Target price
Perf. (%)
€1.26
31.08.22
31.08.22
-
31.08.23
31.08.23
-90.95%
29.05.23
29.05.23
Could be very worthwhile Investment >20% year
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€14.42
29.08.22
29.08.22
-
29.08.23
29.08.23
-59.22%
19.05.23
19.05.23
Could be very worthwhile Investment >20% year
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€6.61
29.08.22
29.08.22
-
29.08.23
29.08.23
-10.43%
15.10.22
15.10.22
Could be very worthwhile Investment >20% year
Novavax Inc.
Start price
Target price
Perf. (%)
€34.98
27.08.22
27.08.22
€16.00
27.08.23
27.08.23
-38.94%
13.10.22
13.10.22
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Tonix Pharmaceuticals Holding Corp.
Start price
Target price
Perf. (%)
€7.13
26.08.22
26.08.22
-
26.08.23
26.08.23
-14.99%
03.09.22
03.09.22
Probably not worthwhile Investment
Invitae Corp
Start price
Target price
Perf. (%)
€3.32
26.08.22
26.08.22
-
26.08.23
26.08.23
-17.03%
03.09.22
03.09.22
Could be very worthwhile Investment >20% year
Daiichi Sankyo Co Ltd
Start price
Target price
Perf. (%)
€31.05
25.08.22
25.08.22
-
25.08.23
25.08.23
-14.11%
26.08.23
26.08.23
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.85
24.08.22
24.08.22
-
24.08.23
24.08.23
-10.03%
03.09.22
03.09.22
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€90.50
24.08.22
24.08.22
€120.00
24.08.23
24.08.23
17.79%
08.05.23
08.05.23
Could be worthwhile Investment >10% per year
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€5.40
23.08.22
23.08.22
-
23.08.23
23.08.23
29.96%
09.09.22
09.09.22
Capable Management
Probably not worthwhile Investment
Revenue decline/stagnation expected
Axsome Therapeutics Inc
Start price
Target price
Perf. (%)
€65.38
23.08.22
23.08.22
-
23.08.23
23.08.23
6.12%
23.08.23
23.08.23
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€36.50
22.08.22
22.08.22
€66.00
22.08.23
22.08.23
-8.22%
03.09.22
03.09.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€25.58
22.08.22
22.08.22
€44.00
22.08.23
22.08.23
-5.00%
03.09.22
03.09.22
Could be very worthwhile Investment >20% year
Capable Management
Good culture
Innovative
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€64.74
22.08.22
22.08.22
€80.00
22.08.23
22.08.23
8.80%
23.08.23
23.08.23
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Mediwound Ltd.
Start price
Target price
Perf. (%)
€1.99
22.08.22
22.08.22
-
22.08.23
22.08.23
-7.04%
04.09.22
04.09.22
Could be very worthwhile Investment >20% year
Mediwound Ltd.
Start price
Target price
Perf. (%)
€1.99
22.08.22
22.08.22
€4.00
22.08.23
22.08.23
-7.04%
04.09.22
04.09.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€76.50
21.08.22
21.08.22
€230.00
21.08.23
21.08.23
6.54%
04.09.22
04.09.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€214.90
21.08.22
21.08.22
€87.00
21.08.23
21.08.23
-3.44%
04.09.22
04.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Invitae Corp
Start price
Target price
Perf. (%)
€3.50
21.08.22
21.08.22
€1.00
21.08.23
21.08.23
-21.28%
04.09.22
04.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Poxel S.A.
Start price
Target price
Perf. (%)
€2.49
20.08.22
20.08.22
-
20.08.23
20.08.23
-75.54%
07.06.23
07.06.23
Could be worthwhile Investment >10% per year
Mediwound Ltd.
Start price
Target price
Perf. (%)
€2.00
19.08.22
19.08.22
-
19.08.23
19.08.23
470.00%
08.01.23
08.01.23
Risky Investment